CORONA Remedies Limited (BOM:544644)
India · Delayed Price · Currency is INR 2,197.90
+47.05 (2.19%)
At close: Oct 28, 2026
CORONA Remedies Market Cap
CORONA Remedies has a market cap or net worth of 134.59 billion as of October 28, 2026.
Market Cap
134.59B
Enterprise Value
135.95B
Revenue
14.79B
Global Rank
n/a
Country Rank
n/a
PE Ratio
67.53
ChartMarket Cap Chart
Since December 15, 2025, CORONA Remedies's market cap has increased from 87.97B to 134.59B, an increase of 52.99%. That is a compound annual growth rate of 63.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 134.59B | 58.90% |
| Dec 31, 2025 | 84.70B | -3.72% |
| Dec 15, 2025 | 87.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rubicon Research | 258.89B |
| Pfizer | 170.84B |
| Marksans Pharma | 138.31B |
| CORONA Remedies | 134.59B |
| Sanofi Consumer Healthcare India | 76.53B |
| Senores Pharmaceuticals | 60.99B |
| SMS Pharmaceuticals | 44.53B |
| Sai Parenteral's | 21.38B |